Feb. 15, 2023 – The manufacturer, Emergent Biosolutions, said it would revise the packaging and labeling to address those concerns. The FDA will make a final decision on the drug in coming weeks. Panel members urged the FDA to move swiftly rather than waiting for Emergent to conduct a follow-up study with the easier-to-understand label. There’s perhaps a far greater risk of delaying the availability of the product given the climate of this crisis and its devastating consequences,” said Maria Coyle, a pharmacy professor from Ohio State University, who chaired the panel.
The prefilled nasal device, Narcan, is the leading version of the drug in the U.S., which is also available as an injection. If FDA approves, Narcan would be the first opioid treatment to make the regulatory switch to a non-prescription drug.
MEASLY AMOUNT – May 3, 2024 - Amneal Pharmaceuticals reached an agreement to pay…
VIDEO – THE ANGEL WEARS NADA – Mar. 26, 2024 - “I knew deep…
HIGHER POWER BARK – April 29, 2024 - An Arizona-based nonprofit has reached the…
VIDEO ONLY – ONE WILL GET YOU TEN – May, 2024 - Actor, Tom…
VIDEO – GOOD MORNING - NOT – May 2, 2024 - A Kentucky boy…
VIDEO – ONE LAST SHOT – May 1, 2024 - His family says he…